This is not very good, the number of capsules sold is also low, not even 10 capsules per system in the field this quarter, that is a very low utilization rate, something is fishy, either the utility of the system is not as great as I expected, or they are not moving toward the colon, where the majority of procedures in the future should be. By now I would have thought that they would start and replace colonoscopy with capsules, but I was wrong. I would stay away for now and if the market stinks, I would not be surprised to see it going even under $5 where I will reexamine this one again. Price wise, we'll have to see if $7 hold on the next decline, if it does, maybe things are better than I estimate right now. Took a little profit from BGEN selling here at $34.48 ($.73).
Zeev